Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

Pfizer, Lilly and Merck partner for cancer research

February 23, 2010
Research and Development Asia, Cancer, developing world, em, emerging markets

Three pharma companies have formed a not-for-profit organisation, the Asian Cancer Research Group (ACRG), to boost work on treating common …

News
Boehringer building at night

Boehringer targets ‘genome guardian’ protein for cancer collaboration

January 19, 2010
Research and Development Boehringer, Cancer, Priaxon, genome

Boehringer Ingelheim has signed a worldwide deal with Munich-based pharma firm Priaxon to find novel treatments for cancer. The firms …

News
Pfizer

Pfizer signs ‘personalised’ cancer collaboration

January 15, 2010
Research and Development Cancer, Debiopharm, Pfizer, melanoma, skin cancer, tremelimumab

Pfizer is to co-develop its monoclonal antibody treatment for advanced melanoma with Swiss company Debiopharm. The companies will conduct phase …

News
BI Centre_03 2

Boehringer’s ovarian cancer drug enters phase III

December 18, 2009
Research and Development, Sales and Marketing Boehringer, Cancer, ovarian

Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …

News

UK faces north/south divide on cancer

December 1, 2009
Sales and Marketing Cancer, NHS

There is a marked north/south divide when it comes to cancer patients’ chances of recovery, according to new statistics. The …

News
Tarceva tablets

Comparing notes: UK’s cancer leaders discuss the latest advances

October 28, 2009
Research and Development, Sales and Marketing Cancer

 

Feature

GSK kidney cancer drug approved in US

October 20, 2009
Research and Development, Sales and Marketing Cancer, GSK, rcc

 GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …

News

FDA revises cancer vaccine guidance

October 12, 2009
Sales and Marketing Cancer, US, reg, vacccine

There are concerns that draft guidance from the US Food and Drug Administration, which will recommend that cancer vaccine trials …

News

AZ signs biomarker research deal

October 5, 2009
Research and Development AZ, Cancer

A deal between AstraZeneca and Cancer Research UK is set to expand biomarker research into how new drugs behave in …

News

Nexavar shows promise in breast cancer

September 24, 2009
Sales and Marketing Cancer, Nexavar, breast cancer

 Bayer’s Nexavar has been shown to significantly extend progression-free survival in patients with advanced breast cancer in a new phase …

News

Merck’s osteoporosis candidate shows some promise in trials

September 16, 2009
Research and Development, Sales and Marketing Cancer, Merck

Merck & Co's investigational cathepsin K inhibitor odanacatib has shown some promise in a trial to treat osteoporosis in postmenopausal …

News

New cancer cases set to hit 17 million by 2020

September 2, 2009
Research and Development, Sales and Marketing Cancer, healthcare

The next ten years will see a 30% leap in the number of new cancer cases across the world, according …

News

Off-label rules for cancer need to be clarified

August 18, 2009
Research and Development, Sales and Marketing Cancer, NHS, off label

A new report is pressing for the off label prescribing of drugs to be made clearer and more fair for …

News

Afinitor approved in EU

August 6, 2009
Research and Development, Sales and Marketing Afinitor, Cancer, Europe, Novartis

Novartis’ new kidney cancer drug Afinitor (everolimus) has been approved in the EU for use when products such as Sutent …

News

Boehringer’s lung cancer candidate enters phase III

August 5, 2009
Research and Development, Sales and Marketing Boehringer, Cancer

Boehringer Ingelheim is to enter phase III studies with a candidate to treat a subset of patients with non-small cell …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026